Search Results - "Semykin, S Iu"

Burkholderia cepacia persistence in patients with mucoviscidosis by Chernukha, M Iu, Shaginian, I A, Kapranov, N I, Alekseeva, G V, Kashirskaia, N Iu, Avetisian, L R, Semykin, S Iu, Danilina, G A, Polikarpova, S V, Pivkina, N V

“…Study features of persistence of Burkholderia cepacia in mucoviscidosis patients. In the period from 2008 to 2009, 56 B. cepacia strains isolated from children…”
Get more information

Microbial population of lower respiratory tract in children from different age groups with cystic fibrosis by Shaginian, I A, Kapranov, N I, Chernukha, M Iu, Alekseeva, G V, Semykin, S Iu, Avetisian, L R, Kashirskaia, N Iu, Pivkina, N V, Danilina, G A, Batov, A B, Busuek, T P

“…To study microflora of lower respiratory tract of children from different age groups with cystic fibrosis during follow-up for determination of its variability…”
Get more information

Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process by Semykin, S Iu, Postnikov, S S, Polikarpova, S V, Perederko, L V

“…The use of cefoperazone/sulbactam in combination with amikacin in the treatment of 20 patients with mucoviscidosis and exacerbation of bronchopulmonary…”
Get more information

Role of anaerobic flora in development of bronchopulmonary infection in children with mucoviscidosis by Semykin, S Iu, Postnikov, S S, Osipov, G A

Get more information

Clinical and bacteriological efficacy and tolerability of meropenem in the treatment of bronchopulmonary affections in children with mucoviscidosis by Semykin, S Iu, Postnikov, S S, Perederko, L V, Polikarpova, S V, Dubovik, L G

“…Meropenem (in combination with amikacin) was used in the treatment of children and adolescents with mucoviscidosis and severe exacerbation of bronchopulmonary…”
Get more information

Pefloxacin in the treatment of patients with mucoviscidosis by Postnikov, S S, Semykin, S Iu, Polikarpova, S V, Nazhimov, V P

“…It was shown that microbial flora isolated from the bronchial secretion of 39 patients with mucoviscidosis in 1999-2001 consisted in one third (32.8%) of S…”
Get more information

On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data) by Postnikov, S S, Semykin, S Iu, Nazhimov, V P, Novichkova, G A

“…Results of prospective comparative investigation of monofluoroquinolones (ciprofloxacin, ofloxacin, pefloxacin) arthropathy are presented. The trial was…”
Get more information

Efficacy and safety of cefepime in the treatment of bronchopulmonary disease exacerbation in pediatric patients with mucoviscidosis by Semykin, S Iu, Postnikov, S S, Polikarpova, S V, Dubovik, L G, Kolbatova, E S

“…Clinicobacteriological effect of cefepime (in combination with amikacin) was studies in 25 pediatric patients of the age of 7 to 17 years with a mixed form of…”
Get more information

The efficacy and safety of ciprofloxacin in treating children with mucoviscidosis by Postnikov, S S, Semykin, S Iu, Kapranov, N I, Perederko, L V, Polikarpova, S V

“…Ciprofloxacin clinical and bacteriological efficacies, as well as tolerability mainly with respect to chondrotoxicity were evaluated in the treatment of…”
Get more information

Comparative morphological analysis of the articular cartilage, epiphyseal plate, spongy bone, and synovial membrane of the knee joint in children treated and not treated with ciprofloxacin by Postnikov, S S, Nazhimov, V P, Semykin, S Iu, Kapranov, N I

“…Comparative data on he postmortem morphological examination of the knee joint in children treated and not treated with ciprofloxacin while alive are presented…”
Get more information

Evaluation of tolerance and efficacy of pefloxacin in the treatment and prevention of severe infections in children with mucoviscidosis and aplastic anemia by Postnikov, S S, Semykin, S Iu, Kapranov, N I, Perederko, L V, Polikarpova, S V, Khamidullina, K F

“…Pefloxacin (Abaktal) efficacy and safety were investigated at 21 children (7-16 years old) randomized in 2 groups: children with mucoviscidosis and children…”
Get more information

Fluorine level in the bone and cartilage in children treated with ciprofloxacin (data obtained from the femur distal part by Postnikov, S S, Kamenev, A I, Viter, I P, Semykin, S Iu, Kapranov, N I, Nazhimov, V P

“…Comparative data on the content of fluorine in various sections of the left femur distal part, i.e. spongy bone, process zone and articular cartilage are…”
Get more information

Antibiotic therapy of cystic fibrosis in children by Kapranov, N I, Shabalova, L A, Kashirskaia, N Iu, SimonovaO, O I, Voronkova, A Iu, Osipova, I A, Semykin, S Iu, Polikarpova, S V, Postnikov, S S

“…It is postulated that P. aeruginosa in monoculture or in association with Staphylococcus aureus keeps its leading position in chronic bacterial inflammatory…”
Get more information

The safety of ofloxacin by Postnikov, S S, Semykin, S Iu, Efremenkova, O V, Sokolov, A V, Kapranov, N I, Litvinov, D V

“…The data on a comparative study of ofloxacin arthrotoxicity in pediatric and adult patients are presented. The tolerability of ofloxacin used in various doses…”
Get more information

Use of ciprofloxacin in children with mucoviscidosis by Kapranov, N I, Kashirskaia, N Iu, Semykin, S Iu, Belousov, Iu B

“…The efficacy of ciprofloxacin was estimated for the last 3 years in the treatment of 139 children with mucoviscidosis. The drug was mainly used under hospital…”
Get more information

Experience in the conduct of ambulatory care of patients with chronic surgical diseases in a rural region by Semykin, Iu S

Get more information